NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.
- DOI
- 10.1073/pnas.2535550123
- Published
- 2026 May 19
- Container
- Proceedings of the National Academy of Sciences of the United States of America
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1073/pnas.2535550123,
title = {NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.},
author = {White MC and Lange PT and Stewart J and Damania B},
year = {2026},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
doi = {10.1073/pnas.2535550123},
url = {https://doi.org/10.1073/pnas.2535550123}
}RIS
TY - JOUR TI - NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma. AU - White MC AU - Lange PT AU - Stewart J AU - Damania B PY - 2026 JO - Proceedings of the National Academy of Sciences of the United States of America DO - 10.1073/pnas.2535550123 UR - https://doi.org/10.1073/pnas.2535550123 ER -
APA
MC, W., PT, L., J, S., & B, D. (2026). NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2535550123
Source records
- pubmed · retrieved 2026-09-27T06:59:18.965Z